temozolomide has been researched along with hispidulin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fei, Z; He, X; Liu, W; Wang, Y | 1 |
| Chen, Z; Lei, J; Sheng, C; Song, S; Zhu, G; Zhu, J | 1 |
2 other study(ies) available for temozolomide and hispidulin
| Article | Year |
|---|---|
Hispidulin enhances the anti-tumor effects of temozolomide in glioblastoma by activating AMPK.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Dacarbazine; Drug Synergism; Enzyme Activation; Flavones; Glioblastoma; Humans; Reactive Oxygen Species; Signal Transduction; Temozolomide; TOR Serine-Threonine Kinases | 2015 |
Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells
Topics: Antineoplastic Agents, Alkylating; Autophagy; Cell Line, Tumor; Dacarbazine; Flavones; Glioma; Humans; Temozolomide | 2022 |